Serum Neopterin Levels in Children with primary Nephrotic Syndrome
Bakr, A., Rageh, I., El-Azouny, M., Deyab, S., Atwa, M., Lotfy, H. (2003). Serum Neopterin Levels in Children with primary Nephrotic Syndrome. EKB Journal Management System, 3(1), 23-28. doi: 10.21608/geget.2003.47677
Asharf Bakr; Ibrahim Rageh; Mahmoud El-Azouny; Safaa Deyab; Mohamed Atwa; Hend Lotfy. "Serum Neopterin Levels in Children with primary Nephrotic Syndrome". EKB Journal Management System, 3, 1, 2003, 23-28. doi: 10.21608/geget.2003.47677
Bakr, A., Rageh, I., El-Azouny, M., Deyab, S., Atwa, M., Lotfy, H. (2003). 'Serum Neopterin Levels in Children with primary Nephrotic Syndrome', EKB Journal Management System, 3(1), pp. 23-28. doi: 10.21608/geget.2003.47677
Bakr, A., Rageh, I., El-Azouny, M., Deyab, S., Atwa, M., Lotfy, H. Serum Neopterin Levels in Children with primary Nephrotic Syndrome. EKB Journal Management System, 2003; 3(1): 23-28. doi: 10.21608/geget.2003.47677

Serum Neopterin Levels in Children with primary Nephrotic Syndrome

GEGET
Article 4, Volume 3, Issue 1, August 2003, Page 23-28  XML PDF (385.65 K)
Document Type: Original Article
DOI: 10.21608/geget.2003.47677
View on SCiNiTO View on SCiNiTO
Authors
Asharf Bakr1; Ibrahim Rageh1; Mahmoud El-Azouny1; Safaa Deyab1; Mohamed Atwa2; Hend Lotfy1
1Department of Clinical Pathology, Banha Faculty of Medicine, Egypt.
2Departments of Pediatrics and Clinical Pathology, Mansoura Faculty of Medicine, Egypt.
Abstract
Background: Neopterin (NP) is a pyrazino-pyrimidine compound derived from guanosie 5′-triphosphate. NP production has been linked to the activation of cell-mediated immunity. Increases in serum NP concentration and urinary NP excretion have been used as diagnostic markers in various immune-mediated clinical conditions including allograft rejection, infectious diseases autoimmune diseases, and neoplastic diseases.
Objectives: To assess the changes that occur in serum neopterin levels in children with primary nephrotic syndrome (PNS).
Methods: Serum NP levels were measured by ELISA in 38 children with active PNS (27 males, 11 females; aged 6.4 ± 2.9 years) (Group I) and 17 children (11 males, 6 females; aged 7 ± 2.5 years)with PNS in remission (Group II) and 20 age-and sex matched controls. All patients had normal creatinine clearance. Among Group I children, 28 patients were steroid-sensitive (SSNS) while 10 patients were steroid-resistant (SRNS).
Results: Serum NP levels were significantly elevated in Group I patients (median =7.5, range 1.8-10.8 ng/ml) compared to Group II (median = 1.5, range 0.5-2.5 ng/ml, p ˂0.001) and controls (median = 0.6, range 0.1-2.7 ng/ml, p ˂ 0.001). Group II patients had similar NP levels compared to controls (p = 0.71). There was a significant positive correlation between serum NP levels and the degree of proteinuria in Group I patients (r = 0.4, p = 0.01). No significant differences in serum NP levels were noted between SSNS and SRNS patients (p = 0.4).
Conclusions: Serum NP could be used as a marker of the activity of PNS but it could not be used to differentiate between SSNS and SRNS.       
Statistics
Article View: 129
PDF Download: 198